ReviewDrugs in context2018

Anti-angiogenesis therapy, synthetic lethality, and checkpoint inhibition in ovarian cancer: state of the science and novel combinations.

Marisa C Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.